Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Rion
AddedFeb 17, 2024
UpdatedJun 18, 2026
Rion

Rion

Seed

Rion, a clinical-stage biotech company, develops potent, accessible regenerative medicine via exosome therapeutics.

HQ
Rochester, MN, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Rion, founded as a clinical-stage biotechnology company, focuses on developing exosome therapeutics to advance regenerative medicine. Their core mission is to create potent, accessible treatments that harness the power of exosomes for tissue repair and regeneration. The company's flagship product, Purified Exosome Product™ (PEP™), has shown significant potential in repairing various injuries and conditions, positioning Rion at the forefront of innovative medical solutions.

Notable figures associated with Rion include leading scientists and researchers in the field of regenerative medicine. The company has attracted significant interest from investors focused on pioneering biotech advancements. Key achievements include successful preclinical studies demonstrating the efficacy of PEP™ and strategic partnerships with research institutions. Rion's impact lies in its potential to revolutionize treatment paradigms for a range of medical conditions, contributing to the broader field of regenerative medicine.

Rion - Similar Companies

ZEO ScientifiX logo

ZEO ScientifiX

organicell.com

SironRX Therapeutics logo

SironRX Therapeutics

sironrx.com

Xostem logo

Xostem

Mantra Bio logo

Mantra Bio

mantrabio.com

RegeneRx Biopharmaceuticals logo

RegeneRx Biopharmaceuticals

iReprogram logo

iReprogram

ireprogram.com

Rbio logo

Rbio

rbio.online

PMGC Holdings logo

PMGC Holdings

Rani Therapeutics Holdings logo

Rani Therapeutics Holdings

EndoCellutions logo

EndoCellutions

endocellutions.com

River 2 Renal logo

River 2 Renal

Amnio Technology logo

Amnio Technology

Spheringenics logo

Spheringenics

Ribon Therapeutics logo

Ribon Therapeutics

ribontx.com

RenaMed Biologics logo

RenaMed Biologics

Rion - Quick Facts

Who are Rion's competitors?

Companies similar to Rion include ZEO ScientifiX, SironRX Therapeutics, Xostem and Mantra Bio.

When was Rion founded?

Rion was founded in 2017.

Where is Rion's headquarters located?

Rion's headquarters is located in Rochester, MN, US.

When was Rion's last funding round?

Rion's most recent funding round was for $1k (USD) in June 2017.

How much has Rion raised to-date?

As of Jun 29, 2017, Rion has raised a total of $1k (USD).

How many employees does Rion have?

Rion has 42 employees as of Feb 5, 2024.

Rion - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Exosomes
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research